Literature DB >> 10947546

A fair approach to discounting future effects: taking a societal perspective.

W Brouwer1, B van Hout, F Rutten.   

Abstract

It is usually recommended that future costs and health effects are discounted at the same rate, usually 5%. In this paper it is argued that, from a societal perspective, this approach may be inappropriate for health effects. Instead of basing the discount rate for health effects on that for costs, it should be based on the real change in the (societal) valuation of health effects over time. Such valuation may change because of increasing life-expectancy and diminishing marginal utility of additional health effects over time.

Mesh:

Year:  2000        PMID: 10947546     DOI: 10.1177/135581960000500210

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  10 in total

1.  Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.

Authors:  Mareike Schad; Jürgen John
Journal:  Eur J Health Econ       Date:  2010-12-19

2.  Need for differential discounting of costs and health effects in cost effectiveness analyses.

Authors:  Werner B F Brouwer; Louis W Niessen; Maarten J Postma; Frans F H Rutten
Journal:  BMJ       Date:  2005-08-20

3.  Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy.

Authors:  Suzanne Polinder; Willem Jan Meerding; Job van Exel; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Evaluating the Cost-Effectiveness of an Early Detection of Parkinson's Disease through Innovative Technology.

Authors:  David A Munoz; Mehmet Serdar Kilinc; Harriet B Nembhard; Conrad Tucker; Xuemei Huang
Journal:  Eng Econ       Date:  2017-03-22       Impact factor: 0.861

5.  Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial.

Authors:  S Petrou; L Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

Review 6.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration.

Authors:  Hester V Eeren; Saskia J Schawo; Ron H J Scholte; Jan J V Busschbach; Leona Hakkaart
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  Users' guide to the orthopaedic literature: what is a cost-effectiveness analysis?

Authors:  Stephanie Tanner; Sheila Sprague; Kyle Jeray
Journal:  Indian J Orthop       Date:  2008-04       Impact factor: 1.251

9.  Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.

Authors:  Susan G Moore; Pareen J Shenoy; Laura Fanucchi; John W Tumeh; Christopher R Flowers
Journal:  BMC Health Serv Res       Date:  2009-01-13       Impact factor: 2.655

10.  Differential discounting in the economic evaluation of healthcare programs.

Authors:  Jürgen John; Florian Koerber; Mareike Schad
Journal:  Cost Eff Resour Alloc       Date:  2019-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.